4.5 Review

Neurokinin-1 receptor antagonists for the prevention of postoperative nausea and vomiting

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

PONV management in patients with QTc prolongation on the EKG

S. Soghomonyan et al.

Summary: Postoperative nausea and vomiting (PONV) is a common issue in surgical practice, which can delay discharge and increase morbidity. While there are many effective drugs to treat or prevent PONV, some of them may increase the risk of serious arrhythmias in patients with prolonged QTc intervals.

FRONTIERS IN PHARMACOLOGY (2021)

Article Anesthesiology

Effect of combinations of dexamethasone-ondansetron and dexamethasone-ondansetron-aprepitant versus aprepitant alone for early postoperative nausea and vomiting after day care gynaecological laparoscopy: A randomised clinical trial

Ingilala L. Thanuja et al.

Summary: The study compared the effectiveness of different antiemetic regimens in preventing postoperative nausea and vomiting in day care gynecologic laparoscopy. The combination of aprepitant, dexamethasone, and ondansetron did not show statistically significant superiority over other regimens in this study.

INDIAN JOURNAL OF ANAESTHESIA (2021)

Review Anesthesiology

Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: an abridged Cochrane network meta-analysis

S. Weibel et al.

Summary: Postoperative nausea and vomiting is a common adverse effect of anesthesia, and this study systematically reviewed the efficacy and safety of various anti-emetics used for prevention. The findings show that combinations of drugs are generally more effective than single drugs, with certain single drugs demonstrating high effectiveness in preventing postoperative vomiting. However, there is still a considerable lack of evidence regarding the safety aspects of these drugs, warranting further investigation.

ANAESTHESIA (2021)

Article Anesthesiology

Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting

Tong J. Gan et al.

ANESTHESIA AND ANALGESIA (2020)

Review Medicine, General & Internal

Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis

Stephanie Weibel et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)

Review Pharmacology & Pharmacy

Neurokinin-1 receptor antagonists: review of their role for the prevention of chemotherapy-induced nausea and vomiting in adults

Meinolf Karthaus et al.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)

Article Oncology

HTX-019 via 2-min injection or 30-min infusion in healthy subjects

Thomas Ottoboni et al.

FUTURE ONCOLOGY (2019)

Article Anesthesiology

Aprepitant as a fourth antiemetic prophylactic strategy in high-risk patients: a double-blind, randomized trial

L. C. de Morais et al.

ACTA ANAESTHESIOLOGICA SCANDINAVICA (2018)

Review Chemistry, Medicinal

Differential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CINV)

Noha Rashad et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2017)

Article Pharmacology & Pharmacy

Rolapitant Absolute Bioavailability and PET Imaging Studies in Healthy Adult Volunteers

X. Wang et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)

Article Anesthesiology

Aprepitant for antiemesis after laparoscopic gynaecological surgery A randomised controlled trial

Sung Yeon Ham et al.

EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2016)

Review Biochemistry & Molecular Biology

Why receptor reserve matters for neurokinin1 (NK1) receptor antagonists

David G. Trist et al.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2013)

Article Pharmacology & Pharmacy

Postoperative Nausea and Vomiting Prophylaxis From an Economic Point of View

Roger Dzwonczyk et al.

AMERICAN JOURNAL OF THERAPEUTICS (2012)

Article Anesthesiology

A time-motion economic analysis of postoperative nausea and vomiting in ambulatory surgery

Ivan Parra-Sanchez et al.

CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2012)

Article Pharmacology & Pharmacy

Effect of single and repeat doses of casopitant on the pharmacokinetics of CYP450 3A4 substrates midazolam and nifedipine

Stefano Zamuner et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)

Article Anesthesiology

Lack of Effect of Aprepitant or Its Prodrug Fosaprepitant on QTc Intervals in Healthy Subjects

Thomas C. Marbury et al.

ANESTHESIA AND ANALGESIA (2009)

Article Pharmacology & Pharmacy

Disposition and Metabolism of Radiolabeled Casopitant in Humans

Mario Pellegatti et al.

DRUG METABOLISM AND DISPOSITION (2009)

Article Pharmacology & Pharmacy

Tolerability of fosaprepitant and bioequivalency to aprepitant in healthy subjects

Kenneth C. Lasseter et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2007)

Article Medicine, General & Internal

Postoperative nausea and vomiting following inpatient surgeries in a teaching hospital: a retrospective database analysis

Ashraf S. Habib et al.

CURRENT MEDICAL RESEARCH AND OPINION (2006)